337 related articles for article (PubMed ID: 29723763)
1. Behavioral activation therapy during transcranial magnetic stimulation for major depressive disorder.
Russo GB; Tirrell E; Busch A; Carpenter LL
J Affect Disord; 2018 Aug; 236():101-104. PubMed ID: 29723763
[TBL] [Abstract][Full Text] [Related]
2. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
[TBL] [Abstract][Full Text] [Related]
3. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
[TBL] [Abstract][Full Text] [Related]
4. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
[TBL] [Abstract][Full Text] [Related]
5. Optimally combining transcranial magnetic stimulation with antidepressants in major depressive disorder: A systematic review and Meta-analysis.
Rakesh G; Cordero P; Khanal R; Himelhoch SS; Rush CR
J Affect Disord; 2024 Aug; 358():432-439. PubMed ID: 38740269
[TBL] [Abstract][Full Text] [Related]
6. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
[TBL] [Abstract][Full Text] [Related]
7. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
[TBL] [Abstract][Full Text] [Related]
8. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
[TBL] [Abstract][Full Text] [Related]
9. Clinical repetitive transcranial magnetic stimulation for veterans with major depressive disorder.
Kozel FA; Hernandez M; Van Trees K; Phillips S; Hashimie J; Weisman M; Obregon D; Sanchez DL; Catalano G; Schultz SK
Ann Clin Psychiatry; 2017 Nov; 29(4):242-248. PubMed ID: 29069109
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
[TBL] [Abstract][Full Text] [Related]
12. Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis.
Lan MJ; Chhetry BT; Liston C; Mann JJ; Dubin M
Brain Stimul; 2016; 9(4):577-83. PubMed ID: 27017072
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression.
Feffer K; Lapidus KAB; Braw Y; Bloch Y; Kron S; Netzer R; Nitzan U
Eur Psychiatry; 2017 Jul; 44():61-67. PubMed ID: 28545010
[TBL] [Abstract][Full Text] [Related]
14. Peripheral vascular endothelial growth factor changes after transcranial magnetic stimulation in treatment-resistant depression.
Fukuda AM; Hindley LE; Kang JWD; Tirrell E; Tyrka AR; Ayala A; Carpenter LL
Neuroreport; 2020 Nov; 31(16):1121-1127. PubMed ID: 32956213
[TBL] [Abstract][Full Text] [Related]
15. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
[TBL] [Abstract][Full Text] [Related]
16. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
Janicak PG; Dunner DL; Aaronson ST; Carpenter LL; Boyadjis TA; Brock DG; Cook IA; Lanocha K; Solvason HB; Bonneh-Barkay D; Demitrack MA
CNS Spectr; 2013 Dec; 18(6):322-32. PubMed ID: 23895940
[TBL] [Abstract][Full Text] [Related]
17. Synergistic use of deep TMS therapy with IV ketamine infusions for major depressive disorder: a pilot study.
Shanok NA; Muzac S; Brown L; Barrera M; Rodriguez R
Psychopharmacology (Berl); 2024 Jul; 241(7):1427-1433. PubMed ID: 38472415
[TBL] [Abstract][Full Text] [Related]
18. Increase of frontal cerebral blood volume during transcranial magnetic stimulation in depression is related to treatment effectiveness: A pilot study with near-infrared spectroscopy.
Shinba T; Kariya N; Matsuda S; Matsuda H; Obara Y
Psychiatry Clin Neurosci; 2018 Aug; 72(8):602-610. PubMed ID: 29774621
[TBL] [Abstract][Full Text] [Related]
19. Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.
Rosenquist PB; Krystal A; Heart KL; Demitrack MA; McCall WV
Psychiatry Res; 2013 Jan; 205(1-2):67-73. PubMed ID: 23021320
[TBL] [Abstract][Full Text] [Related]
20. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
